Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Furie, B C

Class:IdPerson:5607053
_displayNameFurie, B C
_timestamp2014-07-09 14:34:59
created[InstanceEdit:5607040] Jupe, Steve, 2014-07-09
firstnameB C
initialBC
surnameFurie
(author)[LiteratureReference:5607060] Binding of human factor VIII to phospholipid vesicles
[LiteratureReference:9670311] Membrane binding kinetics of factor VIII indicate a complex binding process
[LiteratureReference:9670676] Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX
[LiteratureReference:9670687] Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells
[LiteratureReference:9673198] Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events
[LiteratureReference:9673203] Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa
[LiteratureReference:9673214] Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor
[LiteratureReference:9673402] Molecular defects of factor IX Chicago-2 (Arg 145----His) and prothrombin Madrid (Arg 271----cys): arginine mutations that preclude zymogen activation
[LiteratureReference:9934591] Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis
[LiteratureReference:9934594] Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX
List all 11 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Furie, B C (5607053)